Infant botulism with Down syndrome.

S Toyoguchi; H Tsugu; A Nariai; Y Kaburagi; Y Asahina; K Ambo; K Katou

doi:10.1111/j.1442-200x.1991.tb01573.x

Home/Archive/PubMed

PubMed · 1838457

Infant botulism with Down syndrome.

S Toyoguchi·H Tsugu·A Nariai·Y Kaburagi·Y Asahina·K Ambo·K Katou

View original source ↗Export metadata ↓

Abstract

A 4-month-old boy with Down syndrome and infant botulism is reported. He was admitted to our hospital with stridor and developed respiratory failure and generalized paralysis. Laboratory examination revealed botulinal toxin type A in his blood and feces. Clostridium botulinum organisms were found in the feces and in the honey which he had been fed. Anti-botulinal toxin was administered on the 10th day of illness. Artificial ventilation was given for 87 days and he survived. This is the 11th known case of infant botulism in Japan. It is possible that other cases remain undiagnosed.

Explore related subjects

Botulinum Antitoxin Botulinum Toxins Botulism Combined Modality Therapy Critical Care Down Syndrome Honey Humans Infant Japan Male Respiration, Artificial Case Reports Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

S Toyoguchi, H Tsugu, A Nariai, Y Kaburagi, Y Asahina, K Ambo, K Katou. 1991. Infant botulism with Down syndrome.. https://doi.org/10.1111/j.1442-200x.1991.tb01573.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2005

Botulism.

Botulism is a rare disease with 4 naturally occurring syndromes: foodborne botulism is caused by ingestion of foods contaminated with botulinum toxin, wound botulism is caused by Clostridium botulinum colonization of a wound and in situ toxin production, infant botulism is caused by intestinal colonization and toxin production, and adult intestinal toxemia botulism is an even rarer form of intestinal colonization and toxin production in adults. Inhalational botulism could result from aerosolization of botulinum toxin, and iatrogenic botulism can result from injection of toxin. All forms of botulism produce the same distinct clinical syndrome of symmetrical cranial nerve palsies followed by descending, symmetric flaccid paralysis of voluntary muscles, which may progress to respiratory compromise and death. The mainstays of therapy are meticulous intensive care (including mechanical ventilation, when necessary) and timely treatment with antitoxin.

Botulinum Antitoxin↗

PubMed2003

[Botulism in servicemen: diagnosis and treatment].

Explore the source record for details and available documents.

Botulinum Antitoxin↗

PubMed2002

Infant botulism.

Although the worldwide incidence of infant botulism is rare, the majority of cases are diagnosed in the United States. An infant can acquire botulism by ingesting Clostridium botulinum spores, which are found in soil or honey products. The spores germinate into bacteria that colonize the bowel and synthesize toxin. As the toxin is absorbed, it irreversibly binds to acetylcholine receptors on motor nerve terminals at neuromuscular junctions. The infant with botulism becomes progressively weak, hypotonic and hyporeflexic, showing bulbar and spinal nerve abnormalities. Presenting symptoms include constipation, lethargy, a weak cry, poor feeding and dehydration. A high index of suspicion is important for the diagnosis and prompt treatment of infant botulism, because this disease can quickly progress to respiratory failure. Diagnosis is confirmed by isolating the organism or toxin in the stool and finding a classic electromyogram pattern. Treatment consists of nutritional and respiratory support until new motor endplates are regenerated, which results in spontaneous recovery. Neurologic sequelae are seldom seen. Some children require outpatient tube feeding and may have persistent hypotonia.

Botulinum Antitoxin↗